As of Nov 27
| +0.02 / +0.66%|
The 4 analysts offering 12-month price forecasts for Pernix Therapeutics Holdings Inc have a median target of 9.50, with a high estimate of 14.00 and a low estimate of 8.00. The median estimate represents a +213.53% increase from the last price of 3.03.
The current consensus among 4 polled investment analysts is to Buy stock in Pernix Therapeutics Holdings Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.